Evidence map›Paper›PMID 25750126›Full record

ReviewThe Journal of biological chemistry2015

Systemic amyloidosis: lessons from β2-microglobulin.

Monica Stoppini, Vittorio Bellotti

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Human wild-type and D76N βFASEB bioAdvances · 2023
    Article
  5. Disease-relevant βNature communications · 2023
    Article
  6. Article
  7. Micro- and Nanoplastics' Effects on Protein Folding and Amyloidosis.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Supersaturation-Dependent Formation of Amyloid Fibrils.Molecules (Basel, Switzerland) · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Predicting stable binding modes from simulated dimers of the D76N mutant ofComputational and structural biotechnology journal · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Sequence-independent recognition of the amyloid structural motif by GFP protein family.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Article
  20. The role of the IThe Journal of biological chemistry · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Monica StoppiniFrom the Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy and.
Vittorio BellottiFrom the Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, 27100 Pavia, Italy and the Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London NW3 2PF, United Kingdom v.bellotti@ucl.ac.uk vbellot@unipv.it.

Funding

Medical Research Council MR/K000187/1Telethon GGP14127
6 · The paper itself

Abstract

β2-Microglobulin is responsible for systemic amyloidosis affecting patients undergoing long-term hemodialysis. Its genetic variant D76N causes a very rare form of familial systemic amyloidosis. These two types of amyloidoses differ significantly in terms of the tissue localization of deposits and for major pathological features. Considering how the amyloidogenesis of the β2-microglobulin mechanism has been scrutinized in depth for the last three decades, the comparative analysis of molecular and pathological properties of wild type β2-microglobulin and of the D76N variant offers a unique opportunity to critically reconsider the current understanding of the relation between the protein's structural properties and its pathologic behavior.

Indexed as

AmyloidAmyloidosisbeta 2-MicroglobulinDoxycyclineHumansModels, MolecularMutationProtein Aggregation, PathologicalProtein ConformationRenal DialysisSingle-Chain AntibodiesAmyloidbeta 2-MicroglobulinDoxycyclineSingle-Chain AntibodiesAmyloidAtomic Force Microscopy (AFM)Fibrillogenesis in VitroGenetic Variant Asp76AsnMechanism of AmyloidogenesisProtein AggregationProtein MisfoldingProtein Structureβ2-Microglobulin

Identifiers

PMID25750126
PMCPMC4400370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.